Ball & Co Wealth Management »

Silverback Therapeutics shares owned by Ball & Co Wealth Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Ball & Co Wealth Management from 13F filings

Historical chart of Ball & Co Wealth Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Ball & Co Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Ball & Co Wealth Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $87k 5.0k 17.40
2025-03-31 $125k 10k 12.50
2024-12-31 $105k 10k 10.50

More positions owned by Ball & Co Wealth Management

Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Specialized Funds Div App Etf (VIG)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Eafe Value Etf (EFV)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Alps Etf Tr Alerian Mlp (AMLP)
Series Portfolios Tr Eldridge Bbb B (CLOZ)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Series Portfolios Tr Eldridge Aaa Clo (CLOX)
Amgen (AMGN)
Ishares Silver Tr Ishares (SLV)
Select Sector Spdr Tr Indl (XLI)
Ishares Tr Russell 2000 Etf (IWM)
Fidelity Covington Trust Enhanced Large (FELG)

View all positions for Ball & Co Wealth Management

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Rubric Capital Management
Sr One Capital Management
Standard Life Aberdeen
Vanguard Group
State Street Corporation
Alliancebernstein
Franklin Resources
Citadel Advisors
Casdin Capital
Geode Capital Management
Southpoint Capital Advisors

View all funds holding Silverback Therapeutics